,29 Tumor cells with underlying defects in genome maintenance, such as FBXO7 deficiency, are hypothesized to be particularly reliant on CHEK1 function for survival, making CHEK1 inhibition an attractive SL strategy in this context. The gene discussed is FBXO7; the disease is neoplasm.